Spectris plc (LON:SXS – Get Free Report) insider Andrew Heath bought 2,406 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were purchased at an average cost of GBX 2,480 ($31.25) per share, for a total transaction of £59,668.80 ($75,196.98).
Spectris Price Performance
Shares of Spectris stock opened at GBX 2,547.60 ($32.11) on Monday. The company’s fifty day simple moving average is GBX 2,626.52 and its two-hundred day simple moving average is GBX 2,912.10. The firm has a market cap of £2.52 billion, a PE ratio of 948.51, a price-to-earnings-growth ratio of 2.74 and a beta of 0.61. The company has a quick ratio of 1.03, a current ratio of 2.36 and a debt-to-equity ratio of 4.37. Spectris plc has a 12-month low of GBX 2,370 ($29.87) and a 12-month high of GBX 3,861 ($48.66).
Analysts Set New Price Targets
SXS has been the subject of a number of research reports. Bank of America reissued a “buy” rating and set a GBX 2,950 ($37.18) target price on shares of Spectris in a research report on Monday, September 2nd. Berenberg Bank raised Spectris to a “buy” rating and upped their price target for the company from GBX 3,520 ($44.36) to GBX 3,920 ($49.40) in a research report on Wednesday, July 24th. Finally, Shore Capital upgraded Spectris to a “buy” rating in a research note on Monday, September 9th. One research analyst has rated the stock with a sell rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, Spectris presently has an average rating of “Moderate Buy” and a consensus target price of GBX 4,707.50 ($59.33).
Spectris Company Profile
Spectris plc provides precision measurement solutions worldwide. It operates through Spectris Scientific, Spectris Dynamics, and Other segments. The Spectris Scientific segment provides advanced sensors and instruments used to measure, analyze, and characterize materials; and monitor ultra-clean manufacturing environments.
Recommended Stories
- Five stocks we like better than Spectris
- With Risk Tolerance, One Size Does Not Fit All
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- The Significance of Brokerage Rankings in Stock Selection
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Spectris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectris and related companies with MarketBeat.com's FREE daily email newsletter.